NovaBridge Biosciences - Ordinary Shares, par value $0.0001 per share (Including Ordinary Shares Underlying American Depository Shares) (NBP)
CUSIP: 44975P103
Q4 2025 13F Holders as of 31 Dec 2025
- Type / Class
- Equity / Ordinary Shares, par value $0.0001 per share (Including Ordinary Shares Underlying American Depository Shares)
- Shares outstanding
- 265,214,861
- Total 13F shares
- 33,200,810
- Share change
- +3,660,868
- Total reported value
- $132,139,164
- Put/Call ratio
- 182%
- Price per share
- $3.98
- Number of holders
- 57
- Value change
- +$14,644,437
- Number of buys
- 35
- Number of sells
- 16
Quarterly Holders Quick Answers
What is CUSIP 44975P103?
CUSIP 44975P103 identifies NBP - NovaBridge Biosciences - Ordinary Shares, par value $0.0001 per share (Including Ordinary Shares Underlying American Depository Shares) in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 44975P103:
Top shareholders of NBP - NovaBridge Biosciences - Ordinary Shares, par value $0.0001 per share (Including Ordinary Shares Underlying American Depository Shares) (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Everest Medicines Ltd |
13D/G
|
Everest Medicines Limited |
16%
|
42,524,716
|
$90,577,645 | $0 | 05 Aug 2025 | |
| JANUS HENDERSON GROUP PLC |
13F
|
Company |
3%
|
7,991,377
|
$30,287,319 | — | 30 Sep 2025 | |
| HHLR ADVISORS, LTD. |
13F
|
Company |
2.3%
|
5,980,568
|
$22,606,547 | — | 30 Sep 2025 | |
| ADAGE CAPITAL PARTNERS GP, L.L.C. |
13F
|
Company |
1.3%
|
3,338,034
|
$12,617,769 | — | 30 Sep 2025 | |
| MORGAN STANLEY |
13F
|
Company |
0.84%
|
2,232,040
|
$8,437,112 | — | 30 Sep 2025 | |
| Ariose Capital Management Ltd |
13F
|
Company |
0.64%
|
1,704,393
|
$6,442,606 | — | 30 Sep 2025 | |
| Exome Asset Management LLC |
13F
|
Company |
0.54%
|
1,439,604
|
$5,441,703 | — | 30 Sep 2025 | |
| Siren, L.L.C. |
13F
|
Individual |
0.44%
|
1,165,957
|
$4,407,317 | — | 30 Sep 2025 | |
| S.c.a. Candriam |
13F
|
Individual |
0.43%
|
1,132,563
|
$4,281,088 | — | 30 Sep 2025 | |
| Woodline Partners LP |
13F
|
Company |
0.4%
|
1,050,000
|
$3,969,000 | — | 30 Sep 2025 | |
| Point72 Hong Kong Ltd |
13F
|
Company |
0.21%
|
561,366
|
$2,121,963 | — | 30 Sep 2025 | |
| SG Americas Securities, LLC |
13F
|
Company |
0.17%
|
463,894
|
$1,754,000 | — | 30 Sep 2025 | |
| BARCLAYS PLC |
13F
|
Company |
0.15%
|
395,431
|
$1,494,729 | — | 30 Sep 2025 | |
| STATE STREET CORP |
13F
|
Company |
0.13%
|
337,400
|
$1,275,372 | — | 30 Sep 2025 | |
| UBS Group AG |
13F
|
Company |
0.11%
|
295,078
|
$1,115,395 | — | 30 Sep 2025 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.08%
|
218,470
|
$825,817 | — | 30 Sep 2025 | |
| Connor, Clark & Lunn Investment Management Ltd. |
13F
|
Company |
0.06%
|
164,064
|
$620,162 | — | 30 Sep 2025 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.06%
|
150,164
|
$567,620 | — | 30 Sep 2025 | |
| SUPERSTRING CAPITAL MANAGEMENT LP |
13F
|
Company |
0.05%
|
139,886
|
$528,769 | — | 30 Sep 2025 | |
| BNP PARIBAS FINANCIAL MARKETS |
13F
|
Company |
0.05%
|
119,512
|
$451,755 | — | 30 Sep 2025 | |
| ALPS ADVISORS INC |
13F
|
Company |
0.04%
|
111,490
|
$421,432 | — | 30 Sep 2025 | |
| LMR Partners LLP |
13F
|
Company |
0.04%
|
100,000
|
$378,000 | — | 30 Sep 2025 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
0.04%
|
98,776
|
$373,373 | — | 30 Sep 2025 | |
| Point72 Asset Management, L.P. |
13F
|
Company |
0.03%
|
77,348
|
$292,376 | — | 30 Sep 2025 | |
| XTX Topco Ltd |
13F
|
Company |
0.03%
|
72,104
|
$272,553 | — | 30 Sep 2025 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.02%
|
63,600
|
$240,408 | — | 30 Sep 2025 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.02%
|
54,562
|
$206,244 | — | 30 Sep 2025 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.02%
|
53,949
|
$203,927 | — | 30 Sep 2025 | |
| Aberdeen Group plc |
13F
|
Company |
0.02%
|
43,738
|
$165,330 | — | 30 Sep 2025 | |
| NOMURA HOLDINGS INC |
13F
|
Company |
0.01%
|
25,200
|
$95,256 | — | 30 Sep 2025 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.01%
|
22,453
|
$84,872 | — | 30 Sep 2025 | |
| CITIGROUP INC |
13F
|
Company |
0.01%
|
22,233
|
$84,041 | — | 30 Sep 2025 | |
| Squarepoint Ops LLC |
13F
|
Company |
0%
|
11,698
|
$44,218 | — | 30 Sep 2025 | |
| Walleye Capital LLC |
13F
|
Company |
0%
|
11,000
|
$41,580 | — | 30 Sep 2025 | |
| JANE STREET GROUP, LLC |
13F
|
Company |
0%
|
10,273
|
$38,832 | — | 30 Sep 2025 | |
| Freestone Capital Holdings, LLC |
13F
|
Company |
0%
|
10,000
|
$37,800 | — | 30 Sep 2025 | |
| PUBLIC EMPLOYEES RETIREMENT SYSTEM OF OHIO |
13F
|
Company |
0%
|
9,865
|
$37,290 | — | 30 Sep 2025 | |
| ROYAL BANK OF CANADA |
13F
|
Company |
0%
|
6,360
|
$24,000 | — | 30 Sep 2025 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0%
|
4,617
|
$17,452 | — | 30 Sep 2025 | |
| PNC FINANCIAL SERVICES GROUP, INC. |
13F
|
Company |
0%
|
1,000
|
$3,780 | — | 30 Sep 2025 | |
| RHUMBLINE ADVISERS |
13F
|
Company |
0%
|
33
|
$124 | — | 30 Sep 2025 | |
| OSAIC HOLDINGS, INC. |
13F
|
Company |
0%
|
30
|
$102 | — | 30 Sep 2025 | |
| SBI Securities Co., Ltd. |
13F
|
Company |
0%
|
5
|
$19 | — | 30 Sep 2025 |
Institutional Holders of NovaBridge Biosciences - Ordinary Shares, par value $0.0001 per share (Including Ordinary Shares Underlying American Depository Shares) (NBP) as of Q4 2025
As of 31 Dec 2025,
NovaBridge Biosciences - Ordinary Shares, par value $0.0001 per share (Including Ordinary Shares Underlying American Depository Shares) (NBP) was held by
57 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
33,200,810 shares.
The largest 10 holders included
JANUS HENDERSON GROUP PLC, HHLR ADVISORS, LTD., MORGAN STANLEY, Siren, L.L.C., Point72 Asset Management, L.P., Ariose Capital Management Ltd, Candriam S.C.A., Woodline Partners LP, ADAGE CAPITAL PARTNERS GP, L.L.C., and MILLENNIUM MANAGEMENT LLC.
This page lists
57
institutional shareholders reporting positions in this security
for the Q4 2025 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q4 2025 vs Q3 2025 Across Filers
Q3 2025 holders
42
Q4 2025 holders
57
Holder diff
15
| Investor | Q3 2025 Shares | Q4 2025 Shares | Share Diff | Share Chg % | Q3 2025 Value $ | Q4 2025 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.